GLYCOSTEM THERAPEUTICS

glycostem-therapeutics-logo

Netherlands-based Glycostem Therapeutics BV, a clinical stage biotech company focused on developing off-the shelf allogeneic cellular immunotherapy using Natural Killer (NK) cells to treat several types of cancer. NK-cells are the bodyโ€™s first line of defence because of the innate ability of NK-cells to rapidly and accurately identify and destroy cells under stress, such as cancer or virally-infected cells. Glycostemโ€™s lead product, oNKordยฎ , is produced in a closed system in Glycostemโ€™s ... state-of-theart production facility in The Netherlands, from which the product can be distributed globally. The platform technology includes ex vivo expansion of a high number of pure and highly activated NK-cells for clinical applications. oNKordยฎ successfully concluded phase I clinical trial (elderly and fragile AML patients), providing solid safety data and strong indication of clinical activity, including response on MRD. Glycostem expects to obtain GMP certification by the end of 2018 and is planning to enter pivotal clinical trial in Q1 2019. Thanks to the six patent families, longstanding technical expertise and resources, as well as โ€˜Orphan Drug Designationโ€™, Glycostem has secured a leadership position in the global NK-cell market.

#People #Website #More

GLYCOSTEM THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
2007-01-01

Address:
Oss, Noord-Brabant, The Netherlands

Country:
The Netherlands

Website Url:
http://www.glycostem.com

Total Employee:
11+

Status:
Active

Contact:
+31 (0) 412 211 001

Email Addresses:
[email protected]

Technology used in webpage:
Google Maps ReCAPTCHA V2 3 To 9 CcTLD Redirects


Current Employees Featured

troels-jordansen_image

Troels Jordansen
Troels Jordansen Chief Executive Officer @ Glycostem Therapeutics
Chief Executive Officer
2016-07-01

jan-spanholtz_image

Jan Spanholtz
Jan Spanholtz Chief Scientific Officern & Founder @ Glycostem Therapeutics
Chief Scientific Officern & Founder
2007-01-01

volker-huppert_image

Volker Huppert
Volker Huppert Chief Development Officer @ Glycostem Therapeutics
Chief Development Officer

didier-haguenauer_image

Didier Haguenauer
Didier Haguenauer Chief Medical Officer @ Glycostem Therapeutics
Chief Medical Officer

hans-henskens_image

Hans Henskens
Hans Henskens Chief Quality Officer @ Glycostem Therapeutics
Chief Quality Officer

virginie-bonnamain_image

Virginie Bonnamain
Virginie Bonnamain Medical Director @ Glycostem Therapeutics
Medical Director
2020-07-01

kai-pinkernell_image

Kai Pinkernell
Kai Pinkernell Chief Medical Officer @ Glycostem Therapeutics
Chief Medical Officer
2021-04-01

Founder


jan-spanholtz_image

Jan Spanholtz

Official Site Inspections

http://www.glycostem.com Semrush global rank: 6.83 M Semrush visits lastest month: 755

  • Host name: vip.reactonline.nl
  • IP address: 87.233.157.142
  • Location: Netherlands
  • Latitude: 52.3824
  • Longitude: 4.8995
  • Timezone: Europe/Amsterdam

Loading ...

More informations about "Glycostem Therapeutics" on Search Engine